Skip to main content
SpringerLink
Log in

Subjects High in Anxiety and Low in Perceived Self-Efficacy Tend to Report More Adverse Events in Phase I studies

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Research and Development, BIAL - Portela & C, SA, Portugal

    L. Almeida, H. Gama, M. Vaz-da-Silva, T. Nunes & P. Soares-da-Silva

  2. Faculty of Medicine, Institute of Pharmacology and Therapeutics, Porto, Portugal

    L. Almeida, A. Albino-Teixeira & P. Soares-da-Silva

  3. Institute for Molecular and Cell Biology (IBMC), University of Oporto, Portugal

    M. Vaz-da-Silva & A. Albino-Teixeira

  4. Faculty of Medicine, Service of Psychiatry and Mental Health, Porto, Portugal

    R. Coelho

Authors
  1. L. Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Gama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Vaz-da-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Nunes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Coelho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Albino-Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Soares-da-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Almeida, L., Gama, H., Vaz-da-Silva, M. et al. Subjects High in Anxiety and Low in Perceived Self-Efficacy Tend to Report More Adverse Events in Phase I studies. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00093

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00093

Keywords

Search

Navigation